Gene S Cartwright insider trades: Guided Therapeutics (GTHP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gene reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 29, 2015 | GTHP | ↑ Buy | 37,504 | $0.12 | $5K | Direct | Jul 17, 2015 (18d) |
| Jun 20, 2014 | GTHP | ↑ Buy | 76,000 | $0.48 | $37K | Direct | Jun 20, 2014 (0d) |
| Jun 17, 2014 | GTHP | ↑ Buy | 24,000 | $0.49 | $12K | Direct | Jun 18, 2014 (1d) |
| Mar 26, 2014 | NSPH | ↑ Buy | 23,200 | $2.12 | $49K | Direct | Mar 27, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Gene S Cartwright's insider trades
Gene S Cartwright is President & CEO at Guided Therapeutics (GTHP). Since Mar 26, 2014, Gene has reported 4 open-market purchases worth $102K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GTHP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.